| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 71335-0236-2 | 71335-0236 | HUMAN PRESCRIPTION DRUG | zaleplon | zaleplon | CAPSULE | ORAL | 20180323 | N/A | ANDA | ANDA078989 | Bryant Ranch Prepack | ZALEPLON | 5 mg/1 | 60 CAPSULE in 1 BOTTLE (71335-0236-2) |
| 71335-0236-3 | 71335-0236 | HUMAN PRESCRIPTION DRUG | zaleplon | zaleplon | CAPSULE | ORAL | 20211227 | N/A | ANDA | ANDA078989 | Bryant Ranch Prepack | ZALEPLON | 5 mg/1 | 90 CAPSULE in 1 BOTTLE (71335-0236-3) |
| 71335-0236-4 | 71335-0236 | HUMAN PRESCRIPTION DRUG | zaleplon | zaleplon | CAPSULE | ORAL | 20211227 | N/A | ANDA | ANDA078989 | Bryant Ranch Prepack | ZALEPLON | 5 mg/1 | 20 CAPSULE in 1 BOTTLE (71335-0236-4) |